Trial site
Townsville University Hospital
- 21running trials
- 5closed trials
The trials here
What the 26 trials at this site are about, from their registry records.
- Conditions
- Lung cancer5 trials
- Chronic kidney disease2 trials
- Diffuse large B-cell lymphoma2 trials
- Metastatic breast cancer2 trials
- Multiple myeloma2 trials
- Myelodysplastic syndromes2 trials
- Type 2 diabetes2 trials
- Acute myeloid leukaemia1 trial
- Follicular lymphoma1 trial
- Gastric and oesophageal cancer1 trial
- Heart failure1 trial
- High blood pressure1 trial
- and 9 more
- Phase
- Phase 317 trials
- Phase 25 trials
- Phase 12 trials
- Phase 1/22 trials
- Status
- Active, not recruiting10 trials
- Recruiting8 trials
- Completed5 trials
- Not yet recruiting3 trials
- Lead sponsor
- Novo Nordisk A/S3 trials
- Pfizer3 trials
- BeOne Medicines2 trials
- Daiichi Sankyo2 trials
- Takeda2 trials
- and 14 more
Running trials
Not yet recruiting
Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma
Not yet recruiting
Recruiting
Recruiting
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.
Active, not recruiting
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
Recruiting
Active, not recruiting
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Diffuse large B-cell lymphoma2 recruiting
- Lung cancer2 recruiting
- Chronic kidney disease1 recruiting
- Gastric and oesophageal cancer1 recruiting
- High blood pressure1 recruiting
- Immune thrombocytopenia (ITP)1 recruiting
- Metastatic breast cancer1 recruiting
- Myelodysplastic syndromes1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Obesity1 recruiting
Closed trials
Completed
Completed
Completed
Completed
DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma
Recruiting
Site data: ClinicalTrials.govUpdated 13 Nov 2026